Knowledge Center

145 Results Found

This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the supply chain.
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services departments.
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decisions. CER is designed to support healthcare decisions by providing objective conclusions after comparing the effectiveness, benefits, and potential harm of various medical equipment, devices, or treatment options for specific episodes of care or states of disease.   By using objective data provided by CER, healthcare supply chain professionals have the ability to:
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013. The tax is intended to provide an estimated $20 billion in tax revenues to help pay for the expansion of health coverage to 32 million uninsured Americans. Healthcare supply chain leaders have until May 7, 2012, to comment on the way in which the Internal Revenue Service (IRS) intends to implement this new tax.